| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advanced risk signature analysis of inflammation markers in predicting prostate cancer using the Swedish Apolipoprotein-related MOrtality RISk (AMORIS) cohort
|
George, G.
|
|
|
8 |
C |
p.
|
article
|
| 2 |
Benefit of standard systemic treatments of solid tumours in Australia varies by indication, tumour stream, and treatment modality
|
Tang, J.
|
|
|
8 |
C |
p.
|
article
|
| 3 |
Bridging communication gaps: the role of voice-enabled AI in medicine
|
Loeffler, C.M.L.
|
|
|
8 |
C |
p.
|
article
|
| 4 |
Bridging the gap: overcoming barriers to implementing gene expression profiling in clinical practice
|
Valachis, A.
|
|
|
8 |
C |
p.
|
article
|
| 5 |
Challenges in analyzing real-world evidence: analysis of androgen deprivation therapy use for prostate cancer in the REASSURE study
|
Tran, B.
|
|
|
8 |
C |
p.
|
article
|
| 6 |
Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study
|
Martínez-Sáez, O.
|
|
|
8 |
C |
p.
|
article
|
| 7 |
Comparative effectiveness of immunotherapeutic regimens for untreated advanced non-small-cell lung cancer in real-world clinical practice: a Japanese cancer registry cohort study
|
Miyazaki, A.
|
|
|
8 |
C |
p.
|
article
|
| 8 |
Concordance between patient-reported outcomes and CTCAE clinician-reported toxicities during outpatient chemotherapy courses: a retrospective cohort study in routine care
|
Huynh-Dagher, S.
|
|
|
8 |
C |
p.
|
article
|
| 9 |
Development and validation of a clinical prediction model for hospitalization after emergency department admission in patients with cancer
|
Kaplan, Z.L.R.
|
|
|
8 |
C |
p.
|
article
|
| 10 |
Editoiral Board
|
|
|
|
8 |
C |
p.
|
article
|
| 11 |
Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis
|
Stelmach, R.
|
|
|
8 |
C |
p.
|
article
|
| 12 |
Establishment of the Campania Oncology Network (Rete Oncologica Campana, ROC): a paradigm shift in oncological care and real world research in the Campania region
|
Coppola, E.
|
|
|
8 |
C |
p.
|
article
|
| 13 |
Guy’s Cancer Cohort: Guy’s Cancer Centre’s Real-World Evidence Programme 5 years later
|
Moss, C.L.
|
|
|
8 |
C |
p.
|
article
|
| 14 |
Health care policies, drug costs, and time toxicities in biologics for HER2-positive breast cancer: cost minimization analysis of direct and indirect costs
|
Low, J.L.
|
|
|
8 |
C |
p.
|
article
|
| 15 |
Local and central testing for HER2, PD-L1, MSI/MMR, EBV, and CLDN18.2 in advanced gastric cancer: results from the SAPHIR registry ☆
|
Potthoff, K.
|
|
|
8 |
C |
p.
|
article
|
| 16 |
Machine learning for prediction of 30-day mortality in patients with advanced cancer: comparing pan-cancer and single-cancer models
|
Bjerregaard-Michelsen, S.
|
|
|
8 |
C |
p.
|
article
|
| 17 |
Multimodal identification of a rare head and neck cancer patient cohort in the clinical data warehouse of Greater Paris Teaching Hospital
|
La Rosa, A.
|
|
|
8 |
C |
p.
|
article
|
| 18 |
Observational study on the safety and effectiveness of SARS-CoV-2 vaccination in patients with lung cancer
|
Nadal, E.
|
|
|
8 |
C |
p.
|
article
|
| 19 |
Prevalence of functional iron deficiency in patients with malignancies and its impact on fatigue-specific quality of life
|
Zimmermann, S.
|
|
|
8 |
C |
p.
|
article
|
| 20 |
Prognostic score models for acquired resistance to frontline anti-programmed cell death protein 1/programmed death-ligand 1 therapy in metastatic non-small-cell lung cancer
|
Murray, J.C.
|
|
|
8 |
C |
p.
|
article
|
| 21 |
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression
|
Morimoto, K.
|
|
|
8 |
C |
p.
|
article
|
| 22 |
Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development
|
Navarro-Garcia, D.
|
|
|
8 |
C |
p.
|
article
|
| 23 |
Real-world treatment patterns and survival in patients with synchronous and metachronous metastatic colorectal cancer in the Netherlands
|
Elferink, M.A.G.
|
|
|
8 |
C |
p.
|
article
|
| 24 |
Table of Contents
|
|
|
|
8 |
C |
p.
|
article
|
| 25 |
The complexity of finding fit-for-purpose real-world data for oncology patients with rare NTRK gene fusions and a novel solution
|
Pan, X.
|
|
|
8 |
C |
p.
|
article
|
| 26 |
Three-year analysis of the Belgian multidisciplinary immunotoxicity (BITOX) board: organization, feasibility, and results
|
Verhaert, M.
|
|
|
8 |
C |
p.
|
article
|
| 27 |
Time to adjuvant chemotherapy and overall survival in advanced-stage ovarian cancer patients in England: a population-based retrospective cohort study
|
Steventon, L.
|
|
|
8 |
C |
p.
|
article
|
| 28 |
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019
|
Moscetti, L.
|
|
|
8 |
C |
p.
|
article
|
Journal description